Provided by Tiger Trade Technology Pte. Ltd.

PURAPHARM

0.280
0.000
Volume:- -
Turnover:- -
Market Cap:150.08M
PE:-3.33
High:0.280
Open:0.280
Low:0.280
Close:0.280
52wk High:0.465
52wk Low:0.270
Shares:536.00M
HK Float Shares:536.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.084
ROE:-29.15%
ROA:-1.44%
PB:1.15
PE(LYR):-3.33
PS:0.45

Loading ...

PuraPharm Sets 26 August Board Meeting to Approve 1H 2026 Results and Mull Interim Dividend

Bulletin Express
·
Aug 14

PuraPharm Reports No Share Capital Movements in July 2026; Public Float Remains Compliant

Bulletin Express
·
Aug 06

PURAPHARM Announces Appointment of Zhu Peiqi as Company Secretary and Authorized Representative

Stock News
·
Jul 17

Purapharm Names Dickson Chu Company Secretary, Authorized Representative, Replacing Charmayne Chan

Reuters
·
Jul 17

PuraPharm Reports Stable Share Capital and Sufficient Public Float in June 2026 Monthly Return

Bulletin Express
·
Jul 07

PuraPharm Announces Resignation of Long-Serving INED Prof. Tsui Lap Chee

Bulletin Express
·
Jun 26

PuraPharm Posts Stable May 2026 Share Capital; Public Float Requirement Met

Bulletin Express
·
Jun 04

PuraPharm AGM 2026: All Resolutions Secure 100% Support; Full Board Re-elected, Buy-back & Issuance Mandates Renewed

Bulletin Express
·
May 27

PuraPharm (01498) Endorses Second Amended & Restated Memorandum and Articles; Authorised Share Capital Fixed at US$5.00 Billion

Bulletin Express
·
May 27

PuraPharm shareholders adopt AGM resolutions by poll

Reuters
·
May 27

PuraPharm Keeps Capital Structure Steady in April 2026; 535.90 Million Shares Remain Outstanding

Bulletin Express
·
May 07

PuraPharm announces annual general meeting

Reuters
·
Apr 30

PuraPharm Updates Board Composition and Committee Assignments

Bulletin Express
·
Apr 27

PURAPHARM Appoints Li Jiahui and Wu Hongwei as Independent Non-Executive Directors

Stock News
·
Apr 27

PuraPharm files directors list with Hong Kong Stock Exchange

Reuters
·
Apr 27

PuraPharm appoints Lee Stephen, Ng Wang Wai Charles as independent non-executive directors

Reuters
·
Apr 27

普莱珂医药2025年度业绩:收入下滑与亏损收窄并存,持续深化中医药现代化布局

Bulletin Express
·
Apr 23

Purapharm Announces Online Release of 2025 Annual Report and Implements Full E-Communication Regime

Bulletin Express
·
Apr 23

Purapharm Publishes 2025 Annual Report and Circular, Implements Full Electronic Dissemination

Bulletin Express
·
Apr 23

PuraPharm publishes 2025 annual report

Reuters
·
Apr 23